Better postapproval monitoring of devices advocated in the US
This article was originally published in Clinica
Executive Summary
A more rigorous device-approval process may well remedy some of the concerns surrounding medical devices that have been aired by Congress. But emphasis should also be placed on postapproval monitoring, Dr Alan Garber, writing in the New England Journal of Medicine on 24 March, argues.